JPMorgan adds BridgeBio to focus list, lifts target to $94
Investing.com Gold reports: JPMorgan adds BridgeBio to focus list, lifts target to $94. This is a premium/paywalled source, so the brief is based on headline and available metadata only.
Investing.com Gold reports: JPMorgan adds BridgeBio to focus list, lifts target to $94. This is a premium/paywalled source, so the brief is based on headline and available metadata only.